EPCAM and cancer: It obstructs the nuclear translocation of β-catenin, thereby inhibiting the proliferation of well-differentiated HepG2 and HEK293 cancer cells while also diminishing the proportion of EpCAM + CSCs associated with cancer stemness and tumour progression (In vivo, Mice, i.